Regulus Therapeutics Inc.

Regulus Therapeutics Appoints Hubert C. Chen, M.D., Vice President of Translational Medicine

Published in Health Business Week, October 2nd, 2009

Regulus Therapeutics Inc., a leading microRNA therapeutics company, announced the appointment of Hubert C. Chen, M.D., as Vice President of Translational Medicine. At Regulus, Dr. Chen will be responsible for leading the translation of the important biological discoveries in the field of microRNA therapeutics into new medicines.

"Dr. Chen brings valuable experience and expertise to the ongoing efforts at Regulus as we continue to lead the field in the discovery, development, and commercialization of microRNA therapeutics," said Kleanthis Xanthopoulos, Ph.D., President and Chief Executive Officer of Regulus. "We are delighted to have him join our team as we work towards...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Source: Health Business Week (2009-10-02)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry